Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Liabilities and Shareholders Equity (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $15.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity rose 238.64% year-over-year to $15.5 million, compared with a TTM value of $36.2 million through Sep 2025, up 87.56%, and an annual FY2024 reading of $4.7 million, up 33.79% over the prior year.
  • Liabilities and Shareholders Equity was $15.5 million for Q3 2025 at SeaStar Medical Holding, up from $8.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $15.5 million in Q3 2025 and bottomed at $2.2 million in Q3 2023.
  • Average Liabilities and Shareholders Equity over 3 years is $5.8 million, with a median of $4.6 million recorded in 2024.
  • Peak annual rise in Liabilities and Shareholders Equity hit 238.64% in 2025, while the deepest fall reached 1.85% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $3.5 million in 2023, then soared by 33.79% to $4.7 million in 2024, then skyrocketed by 230.43% to $15.5 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for ICU at $15.5 million in Q3 2025, $8.4 million in Q2 2025, and $7.6 million in Q1 2025.